文本挖掘策略识别miR-21在乳腺癌发展中控制的基因网络

IF 3.1 2区 医学 Q2 ONCOLOGY
Cancer Medicine Pub Date : 2025-06-26 DOI:10.1002/cam4.70986
Hong Ye, Yuyu Wu, Richard Tran, Jie Wang
{"title":"文本挖掘策略识别miR-21在乳腺癌发展中控制的基因网络","authors":"Hong Ye,&nbsp;Yuyu Wu,&nbsp;Richard Tran,&nbsp;Jie Wang","doi":"10.1002/cam4.70986","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>MicroRNAs (miRNAs) are small regulatory molecules that play a critical role in various biological processes by regulating gene expression. They have emerged as crucial players in cancer development, including breast cancer. However, individual research studies may be subject to specific biases.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>To gain a more comprehensive understanding of miRNA involvement in breast cancer, we employed a large-scale analysis of miRNA studies retrieved from PubMed. Our approach involved tokenizing abstracts to identify key biomedical entities (e.g., miRNA, gene, disease) and constructing miRNA-cancer co-occurrence networks using bioinformatic analysis.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>This analysis revealed miR-21 as the most frequently studied miRNA in breast cancer research, with a significant difference compared to other miRNAs. Network analysis identified SMAD3, PIK3R1, STAT3, and TP53 as key regulators potentially affecting pathways like TGF-β signaling and p53 signaling. Additionally, our analysis suggests that genes associated with miR-21 are often downregulated in tumors and exhibit a positive correlation with T cell infiltration, particularly CD8+ T cells, potentially indicating a favorable prognosis.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Our findings highlight miR-21 as a central regulatory hub and potential biomarker in breast cancer. While informative, the results are derived from literature-based data and may be influenced by text-mining limitations, underscoring the need for experimental validation.</p>\n </section>\n </div>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 13","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.70986","citationCount":"0","resultStr":"{\"title\":\"Text Mining Strategy Identifies Gene Networks Under Control of miR-21 in Breast Cancer Development\",\"authors\":\"Hong Ye,&nbsp;Yuyu Wu,&nbsp;Richard Tran,&nbsp;Jie Wang\",\"doi\":\"10.1002/cam4.70986\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>MicroRNAs (miRNAs) are small regulatory molecules that play a critical role in various biological processes by regulating gene expression. They have emerged as crucial players in cancer development, including breast cancer. However, individual research studies may be subject to specific biases.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>To gain a more comprehensive understanding of miRNA involvement in breast cancer, we employed a large-scale analysis of miRNA studies retrieved from PubMed. Our approach involved tokenizing abstracts to identify key biomedical entities (e.g., miRNA, gene, disease) and constructing miRNA-cancer co-occurrence networks using bioinformatic analysis.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>This analysis revealed miR-21 as the most frequently studied miRNA in breast cancer research, with a significant difference compared to other miRNAs. Network analysis identified SMAD3, PIK3R1, STAT3, and TP53 as key regulators potentially affecting pathways like TGF-β signaling and p53 signaling. Additionally, our analysis suggests that genes associated with miR-21 are often downregulated in tumors and exhibit a positive correlation with T cell infiltration, particularly CD8+ T cells, potentially indicating a favorable prognosis.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Our findings highlight miR-21 as a central regulatory hub and potential biomarker in breast cancer. While informative, the results are derived from literature-based data and may be influenced by text-mining limitations, underscoring the need for experimental validation.</p>\\n </section>\\n </div>\",\"PeriodicalId\":139,\"journal\":{\"name\":\"Cancer Medicine\",\"volume\":\"14 13\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-06-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.70986\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cam4.70986\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.70986","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

MicroRNAs (miRNAs)是一种小的调控分子,通过调控基因表达在各种生物过程中起着至关重要的作用。它们已经成为癌症发展的关键因素,包括乳腺癌。然而,个别研究可能会受到特定偏见的影响。为了更全面地了解miRNA与乳腺癌的关系,我们对PubMed上的miRNA研究进行了大规模分析。我们的方法包括对摘要进行标记,以识别关键的生物医学实体(例如,miRNA,基因,疾病),并使用生物信息学分析构建miRNA-癌症共发生网络。该分析显示,miR-21是乳腺癌研究中最常被研究的miRNA,与其他miRNA相比具有显著差异。网络分析发现SMAD3、PIK3R1、STAT3和TP53是可能影响TGF-β信号通路和p53信号通路的关键调节因子。此外,我们的分析表明,与miR-21相关的基因在肿瘤中经常下调,并与T细胞浸润呈正相关,特别是CD8+ T细胞,这可能预示着良好的预后。结论:我们的研究结果强调miR-21是乳腺癌的中心调控枢纽和潜在的生物标志物。虽然信息丰富,但结果来自基于文献的数据,可能受到文本挖掘限制的影响,强调需要实验验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Text Mining Strategy Identifies Gene Networks Under Control of miR-21 in Breast Cancer Development

Text Mining Strategy Identifies Gene Networks Under Control of miR-21 in Breast Cancer Development

Background

MicroRNAs (miRNAs) are small regulatory molecules that play a critical role in various biological processes by regulating gene expression. They have emerged as crucial players in cancer development, including breast cancer. However, individual research studies may be subject to specific biases.

Methods

To gain a more comprehensive understanding of miRNA involvement in breast cancer, we employed a large-scale analysis of miRNA studies retrieved from PubMed. Our approach involved tokenizing abstracts to identify key biomedical entities (e.g., miRNA, gene, disease) and constructing miRNA-cancer co-occurrence networks using bioinformatic analysis.

Results

This analysis revealed miR-21 as the most frequently studied miRNA in breast cancer research, with a significant difference compared to other miRNAs. Network analysis identified SMAD3, PIK3R1, STAT3, and TP53 as key regulators potentially affecting pathways like TGF-β signaling and p53 signaling. Additionally, our analysis suggests that genes associated with miR-21 are often downregulated in tumors and exhibit a positive correlation with T cell infiltration, particularly CD8+ T cells, potentially indicating a favorable prognosis.

Conclusion

Our findings highlight miR-21 as a central regulatory hub and potential biomarker in breast cancer. While informative, the results are derived from literature-based data and may be influenced by text-mining limitations, underscoring the need for experimental validation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer Medicine
Cancer Medicine ONCOLOGY-
CiteScore
5.50
自引率
2.50%
发文量
907
审稿时长
19 weeks
期刊介绍: Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信